FDA Warns Three Baby-Formula Makers Over Violations in Production
By Sabela Ojea
The U.S. Food and Drug Administration issued warning letters to baby-formula manufacturers Reckitt & Benckiser's Mead Johnson Nutrition, Perrigo Wisconsin and ByHeart over their infant formulas.
The U.S. regulator said the three companies violated infant formula regulations, based on data compiled from a number of inspections of their facilities over the past few months.
Each company will have 15 working days to explain what corrective actions they are taking, the FDA said.
The FDA isn't advising parents and caregivers to discard or avoid purchasing any particular infant formula at this time. However, its aim is to make sure infant formula is being produced "under the safest conditions possible."
"The FDA is issuing these letters...to reinforce to these firms the importance of instituting and maintaining appropriate corrective actions when they detect pathogens to ensure compliance with the FDA's laws and regulations," it said.
In December of last year then again in February and March, the FDA initiated formula recalls to remove product potentially contaminated with the bacteria Cronobacter sakazakii.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
August 30, 2023 17:12 ET (21:12 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now